PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32050632-0	2020	Inhibition of USP9X Downregulates JAK2-V617F and Induces Apoptosis Synergistically with BH3 Mimetics Preferentially in Ruxolitinib-Persistent JAK2-V617F-Positive Leukemic Cells.	ruxolitinib	119-130	ubiquitin specific peptidase 9 X-linked	Homo sapiens	14-19	
32050632-8	2020	Thus, USP9X represents a promising target along with anti-apoptotic Bcl-2 family members for novel therapeutic strategies against JAK2-V617F-positive myeloproliferative neoplasms, particularly under the ruxolitinib persistence conditions.	ruxolitinib	203-214	ubiquitin specific peptidase 9 X-linked	Homo sapiens	6-11